|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
EP1065207A1
(en)
*
|
1999-07-02 |
2001-01-03 |
Aventis Pharma Deutschland GmbH |
Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
|
|
DE19948417A1
(de)
*
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
|
DE60039059D1
(de)
|
1999-10-07 |
2008-07-10 |
Amgen Inc |
Triazin-kinase-hemmer
|
|
AP1905A
(en)
|
1999-12-10 |
2008-10-20 |
Pfizer Prod Inc |
Pyrrolo[2,3-d] Pyrimidine Compounds.
|
|
EP1250137B1
(en)
*
|
2000-01-24 |
2007-08-15 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis
|
|
EP1782800B1
(en)
*
|
2000-01-24 |
2013-12-18 |
Genzyme Corporation |
Methods for detecting JAK3 inhibitors
|
|
MY137020A
(en)
*
|
2000-04-27 |
2008-12-31 |
Abbott Lab |
Diazabicyclic central nervous system active agents
|
|
UA74370C2
(ru)
*
|
2000-06-26 |
2005-12-15 |
Пфайзер Продактс Інк. |
Пирроло(2,3-d)пиримидиновые соединения как иммуносупрессоры
|
|
US6864255B2
(en)
|
2001-04-11 |
2005-03-08 |
Amgen Inc. |
Substituted triazinyl amide derivatives and methods of use
|
|
US6881737B2
(en)
|
2001-04-11 |
2005-04-19 |
Amgen Inc. |
Substituted triazinyl acrylamide derivatives and methods of use
|
|
US7301023B2
(en)
*
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
|
AP2003002929A0
(en)
*
|
2001-06-23 |
2003-12-31 |
Aventis Pharma Inc |
Pyrrolopyrimidines as protein kinase inhibitors
|
|
GB0115393D0
(en)
*
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
US7323469B2
(en)
|
2001-08-07 |
2008-01-29 |
Novartis Ag |
7H-pyrrolo[2,3-d]pyrimidine derivatives
|
|
GB0119249D0
(en)
|
2001-08-07 |
2001-10-03 |
Novartis Ag |
Organic compounds
|
|
GT200200234A
(es)
|
2001-12-06 |
2003-06-27 |
|
Compuestos cristalinos novedosos
|
|
US6642381B2
(en)
|
2001-12-27 |
2003-11-04 |
Hoffman-La Roche Inc. |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
|
|
JP4411455B2
(ja)
|
2002-01-07 |
2010-02-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
デアザプリンおよびそれらの用途
|
|
GB0202679D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1388541A1
(en)
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines as kinase inhibitors
|
|
BR0316487A
(pt)
|
2002-11-26 |
2005-10-11 |
Pfizer Prod Inc |
Método todo de tratamento da rejeição de transplantes
|
|
US7253166B2
(en)
*
|
2003-04-22 |
2007-08-07 |
Irm Llc |
6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells
|
|
EP1682564A1
(en)
*
|
2003-10-27 |
2006-07-26 |
Genelabs Technologies, Inc. |
METHODS FOR PREPARING 7-(2 -SUBSTITUTED-s-D-RIBOFURANO SYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO 2,3-D|PYRIMIDINE DERIVATIVES
|
|
WO2005067546A2
(en)
*
|
2004-01-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
|
|
GB0403606D0
(en)
*
|
2004-02-18 |
2004-03-24 |
Novartis Ag |
Organic compounds
|
|
AU2005249380C1
(en)
*
|
2004-04-23 |
2012-09-20 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
US20110104186A1
(en)
|
2004-06-24 |
2011-05-05 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
|
MXPA06015237A
(es)
|
2004-06-29 |
2007-12-10 |
Amgen Inc |
Pirrolo[2-3-d]pirimidinas que modulan la actividad de ack1 y lck.
|
|
JP2008508358A
(ja)
|
2004-08-02 |
2008-03-21 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
アリール−アミノ置換ピロロピリミジンマルチキナーゼ阻害化合物
|
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
FR2880626B1
(fr)
*
|
2005-01-13 |
2008-04-18 |
Aventis Pharma Sa |
Derives de la purine, compositions les contenant et utilisation
|
|
WO2006091450A1
(en)
*
|
2005-02-18 |
2006-08-31 |
Lexicon Genetics Incorporated |
4-piperidin-1-yl-7h-pyrrolo[2,3-d]pyrimidine compounds
|
|
AU2006247757B2
(en)
|
2005-05-13 |
2009-08-27 |
Irm, Llc |
Compounds and compositions as protein kinase inhibitors
|
|
EP1910358A2
(en)
|
2005-07-14 |
2008-04-16 |
Astellas Pharma Inc. |
Heterocyclic janus kinase 3 inhibitors
|
|
CN102127078A
(zh)
|
2005-07-14 |
2011-07-20 |
安斯泰来制药株式会社 |
Janus激酶3的杂环类抑制剂
|
|
EP1926735A1
(en)
|
2005-09-22 |
2008-06-04 |
Incyte Corporation |
Tetracyclic inhibitors of janus kinases
|
|
RU2008117151A
(ru)
*
|
2005-09-30 |
2009-11-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Деазапурины, пригодные в качестве ингибиторов янус-киназ
|
|
AU2015201850B2
(en)
*
|
2005-12-13 |
2017-03-02 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
|
LT2474545T
(lt)
|
2005-12-13 |
2017-02-27 |
Incyte Holdings Corporation |
Heteroarilu pakeisti pirolo[2,3-b]piridinai ir pirolo[2,3-b]pirimidinai kaip janus kinazės inhibitoriai
|
|
JP2009533323A
(ja)
*
|
2006-03-11 |
2009-09-17 |
ヴァーナリス アールアンドディー リミテッド |
Ｈｓｐ９０阻害剤として用いられるピロロピリミジン誘導体
|
|
JP2009532475A
(ja)
*
|
2006-04-05 |
2009-09-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ヤヌスキナーゼの阻害剤として有用なデアザプリン
|
|
EP3421471B1
(en)
|
2006-04-25 |
2021-05-26 |
Astex Therapeutics Limited |
Purine and deazapurine derivatives as pharmaceutical compounds
|
|
GB0608176D0
(en)
*
|
2006-04-25 |
2006-06-07 |
Astex Therapeutics Ltd |
Pharmaceutical Compounds
|
|
WO2008012635A2
(en)
*
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Amine derivatives useful as anticancer agents
|
|
WO2008033745A2
(en)
*
|
2006-09-11 |
2008-03-20 |
Curis, Inc. |
Fused bicyclic pyrimidines as ptk inhibitors containing a zinc binding moiety
|
|
JP2010502743A
(ja)
*
|
2006-09-11 |
2010-01-28 |
キュリス，インコーポレイテッド |
抗増殖薬剤としての多機能性低分子
|
|
AR064416A1
(es)
*
|
2006-12-21 |
2009-04-01 |
Cancer Rec Tech Ltd |
Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
|
|
WO2008075007A1
(en)
*
|
2006-12-21 |
2008-06-26 |
Cancer Research Technology Limited |
Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents
|
|
WO2008079965A1
(en)
|
2006-12-22 |
2008-07-03 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
|
TW200900061A
(en)
|
2007-01-12 |
2009-01-01 |
Astellas Pharma Inc |
Condensed pyridine compound
|
|
CN101679440A
(zh)
*
|
2007-04-02 |
2010-03-24 |
帕劳制药股份有限公司 |
作为jak3抑制剂的吡咯并嘧啶衍生物
|
|
UA99284C2
(ru)
|
2007-05-11 |
2012-08-10 |
Елі Ліллі Енд Компані |
ИНГИБИТОРЫ р70 S6-КИНАЗЫ
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
CA2689663C
(en)
|
2007-06-13 |
2016-08-09 |
Incyte Corporation |
Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
GB0713602D0
(en)
*
|
2007-07-12 |
2007-08-22 |
Syngenta Participations Ag |
Chemical compounds
|
|
JP5536647B2
(ja)
*
|
2007-07-27 |
2014-07-02 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ピロロピリミジン
|
|
AU2008285388B2
(en)
*
|
2007-08-08 |
2013-09-19 |
Lexicon Pharmaceuticals, Inc. |
(7h-pyrrolo [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation
|
|
WO2009030871A1
(en)
*
|
2007-09-07 |
2009-03-12 |
Vernalis R & D Ltd |
Pyrrolopyrimidine derivatives having hsp90 inhibitory activity
|
|
CN101861321B
(zh)
|
2007-10-11 |
2013-02-06 |
阿斯利康(瑞典)有限公司 |
作为蛋白激酶b抑制剂的吡咯并[2,3-d]嘧啶衍生物
|
|
BRPI0820544A2
(pt)
|
2007-11-16 |
2015-06-16 |
Incyte Corp |
4-pirazolil-n-arilpirimidin-2-aminas e pirazolil-n-heteroarilpirimidin-2-aminas como inibidores de janus cinase
|
|
RS55263B1
(sr)
|
2008-03-11 |
2017-02-28 |
Incyte Holdings Corp |
Derivati azetidina i ciklobutana kao jak inhibitori
|
|
US8193202B2
(en)
|
2008-04-21 |
2012-06-05 |
Lexicon Pharmaceuticals, Inc. |
LIMK2 inhibitors, compositions comprising them, and methods of their use
|
|
JP2011518836A
(ja)
|
2008-04-24 |
2011-06-30 |
インサイト・コーポレイション |
大環状化合物およびそれらのキナーゼ阻害剤としての使用
|
|
PT2384326E
(pt)
|
2008-08-20 |
2014-06-09 |
Zoetis Llc |
Compostos de pirrolo[2,3-d]pirimidina
|
|
US8385364B2
(en)
*
|
2008-09-24 |
2013-02-26 |
Nec Laboratories America, Inc. |
Distributed message-passing based resource allocation in wireless systems
|
|
CL2009001884A1
(es)
*
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
JOP20190231A1
(ar)
*
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
|
DE102009005193A1
(de)
*
|
2009-01-20 |
2010-07-22 |
Merck Patent Gmbh |
Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren
|
|
WO2010085597A1
(en)
|
2009-01-23 |
2010-07-29 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
|
WO2010093808A1
(en)
|
2009-02-11 |
2010-08-19 |
Reaction Biology Corp. |
Selective kinase inhibitors
|
|
ES2552805T3
(es)
|
2009-04-20 |
2015-12-02 |
Auspex Pharmaceuticals, Llc |
Inhibidores piperidínicos de la cinasa Janus 3
|
|
DK2432472T3
(da)
|
2009-05-22 |
2019-11-18 |
Incyte Holdings Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octan- eller heptan-nitril som jak-inhibitorer
|
|
BRPI1012159B1
(pt)
*
|
2009-05-22 |
2022-01-25 |
Incyte Holdings Corporation |
Compostos derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d] pirimidinas e pirrol-3-il-pirrolo[2,3-d] pirimidinas como inibidores de janus cinase, composições farmacêuticas compreendendo os referidos compostos e usos dos mesmos
|
|
CA2767079A1
(en)
|
2009-07-08 |
2011-01-13 |
Leo Pharma A/S |
Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
|
|
TWI466885B
(zh)
*
|
2009-07-31 |
2015-01-01 |
Japan Tobacco Inc |
含氮螺環化合物及其醫藥用途
|
|
TW201111385A
(en)
*
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
CA3082212C
(en)
|
2009-09-04 |
2023-03-07 |
Sunesis Pharmaceuticals, Inc. |
Bruton's tyrosine kinase inhibitors
|
|
JP5792171B2
(ja)
*
|
2009-09-04 |
2015-10-07 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
白血病を治療するための組成物および方法
|
|
CA2777114C
(en)
|
2009-10-09 |
2018-10-23 |
Incyte Corporation |
Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
WO2011045702A1
(en)
*
|
2009-10-15 |
2011-04-21 |
Pfizer Inc. |
Pyrrolo[2,3-d] pyrimidine compounds
|
|
US9074143B2
(en)
*
|
2009-12-11 |
2015-07-07 |
Uop Llc |
Process for producing hydrocarbon fuel
|
|
CA2782720A1
(en)
|
2009-12-18 |
2011-06-23 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidine compounds
|
|
US20120309776A1
(en)
|
2010-02-05 |
2012-12-06 |
Pfitzer Inc. |
Pyrrolo[2,3-d]pyrimidine urea compounds as jak inhibitors
|
|
AU2011217961B2
(en)
*
|
2010-02-18 |
2016-05-05 |
Incyte Holdings Corporation |
Cyclobutane and methylcyclobutane derivatives as Janus kinase inhibitors
|
|
KR20220015492A
(ko)
|
2010-03-10 |
2022-02-08 |
인사이트 홀딩스 코포레이션 |
Ｊａｋ１ 저해제로서의 피페리딘４일 아제티딘 유도체
|
|
PL2574168T3
(pl)
|
2010-05-21 |
2016-10-31 |
|
Preparaty inhibitora kinazy janusowej do stosowania miejscowego
|
|
CN102985425A
(zh)
*
|
2010-07-09 |
2013-03-20 |
利奥制药有限公司 |
作为蛋白酪氨酸激酶抑制剂的新的高哌嗪衍生物及其医药用途
|
|
CA2808543C
(en)
*
|
2010-08-20 |
2016-01-26 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
|
CN102372717B
(zh)
*
|
2010-08-20 |
2014-06-18 |
和记黄埔医药（上海）有限公司 |
吡咯并嘧啶类化合物及其用途
|
|
WO2012022045A1
(en)
*
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
|
TWI401258B
(zh)
*
|
2010-09-08 |
2013-07-11 |
Hutchison Medipharma Ltd |
吡咯並嘧啶類化合物及其用途
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
ES2536415T3
(es)
|
2010-11-19 |
2015-05-25 |
Incyte Corporation |
Pirrolopiridinas y pirrolopirimidinas sustituidas heterocíclicas como inhibidores de JAK
|
|
EP2651417B1
(en)
|
2010-12-16 |
2016-11-30 |
Calchan Limited |
Ask1 inhibiting pyrrolopyrimidine derivatives
|
|
WO2012088682A1
(en)
*
|
2010-12-29 |
2012-07-05 |
Shanghai Fochon Pharmaceutical Co Ltd. |
2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
|
|
JP2014501772A
(ja)
*
|
2011-01-07 |
2014-01-23 |
レオ ファーマ アクティーゼルスカブ |
タンパク質チロシンキナーゼ阻害薬としての新規スルファミドピペラジン誘導体およびその医薬用途
|
|
DE102011008352A1
(de)
*
|
2011-01-12 |
2012-07-12 |
Merck Patent Gmbh |
5-([1,2,3]Triazol-4-yl)-7H-pyrrolo-[2,3-d]pyrimidinderivate
|
|
CA2826295C
(en)
|
2011-02-04 |
2020-10-20 |
Duquesne University Of The Holy Spirit |
Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
|
|
ES2547916T3
(es)
|
2011-02-18 |
2015-10-09 |
Novartis Pharma Ag |
Terapia de combinación de inhibidores de mTOR/JAK
|
|
BR112013024267A2
(pt)
|
2011-03-22 |
2018-06-26 |
Advinus Therapeutics Ltd |
compostos tricíclicos fundidos substituídos, composições e aplicações medicinais dos mesmos.
|
|
BR112013025410A2
(pt)
|
2011-04-01 |
2016-12-20 |
Astrazeneca Ab |
tratamento terapêutico
|
|
EP2721028B1
(en)
|
2011-06-20 |
2015-11-04 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
|
CN106946886A
(zh)
*
|
2011-06-29 |
2017-07-14 |
默沙东公司 |
二肽基肽酶‑iv抑制剂的新晶形
|
|
KR20140058543A
(ko)
|
2011-07-08 |
2014-05-14 |
노파르티스 아게 |
신규 피롤로 피리미딘 유도체
|
|
US9358229B2
(en)
|
2011-08-10 |
2016-06-07 |
Novartis Pharma Ag |
JAK PI3K/mTOR combination therapy
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
MX367640B
(es)
|
2011-11-30 |
2019-08-29 |
Astrazeneca Ab |
Tratamiento combinado del cáncer.
|
|
US9089574B2
(en)
|
2011-11-30 |
2015-07-28 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
|
WO2013085802A1
(en)
*
|
2011-12-06 |
2013-06-13 |
Merck Sharp & Dohme Corp. |
Pyrrolopyrimidines as janus kinase inhibitors
|
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
|
WO2013173720A1
(en)
|
2012-05-18 |
2013-11-21 |
Incyte Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
|
MX2014015769A
(es)
*
|
2012-06-29 |
2015-04-10 |
Pfizer |
7h-pirrolo[2,3-d]pirimidinas 4-(amino-substituidas)novedosas como inhibidores de lrrk2.
|
|
AU2013312477B2
(en)
|
2012-09-06 |
2018-05-31 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
US9593115B2
(en)
|
2012-09-21 |
2017-03-14 |
Advinus Therapeutics Ltd. |
Substituted fused tricyclic compounds, compositions, and medicinal applications thereof
|
|
MX2015002975A
(es)
*
|
2012-10-26 |
2015-06-22 |
Hoffmann La Roche |
Inhibidores de la tirosina cinasa de bruton.
|
|
CN102936251A
(zh)
*
|
2012-11-05 |
2013-02-20 |
上海毕得医药科技有限公司 |
一种吡咯并[2,3-d]嘧啶衍生物的制备方法
|
|
PE20200175A1
(es)
|
2012-11-15 |
2020-01-24 |
Incyte Holdings Corp |
Formas de dosificacion de ruxolitinib de liberacion sostenida
|
|
NZ710411A
(en)
|
2013-02-22 |
2017-11-24 |
Pfizer |
Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of janus- related kinases (jak)
|
|
UA120162C2
(uk)
|
2013-03-06 |
2019-10-25 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки при отриманні інгібітора jak
|
|
EP2970119B1
(en)
*
|
2013-03-14 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
CA3155500A1
(en)
|
2013-08-07 |
2015-02-12 |
Incyte Corporation |
Sustained release dosage forms for a jak1 inhibitor
|
|
MA39092B1
(fr)
|
2013-12-05 |
2018-09-28 |
Pfizer |
Pyrrolo[2,3-d]pyrimidinyle, pyrrolo[2,3-b]pyrazinyle et pyrollo[2,3-d]pyridinyle acrylamides
|
|
WO2015092592A1
(en)
|
2013-12-17 |
2015-06-25 |
Pfizer Inc. |
Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
|
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
|
EP3180344B1
(en)
|
2014-08-12 |
2019-09-18 |
Pfizer Inc |
Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase
|
|
WO2016040330A1
(en)
|
2014-09-09 |
2016-03-17 |
The Regents Of The University Of Michigan |
Thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
CN105524067A
(zh)
*
|
2014-09-28 |
2016-04-27 |
江苏柯菲平医药股份有限公司 |
4-取代吡咯并[2,3-d]嘧啶化合物及其用途
|
|
ES2928757T3
(es)
|
2015-05-01 |
2022-11-22 |
Pfizer |
Acrilamidas de pirrolo[2,3-b]pirazinilo y epóxidos de las mismas como inhibidores de la Janus Quinasa
|
|
AR104020A1
(es)
|
2015-06-04 |
2017-06-21 |
Kura Oncology Inc |
Métodos y composiciones para inhibir la interacción de menina con proteínas mill
|
|
WO2016197027A1
(en)
|
2015-06-04 |
2016-12-08 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
|
RU2712269C2
(ru)
*
|
2015-07-31 |
2020-01-28 |
Тайхо Фармасьютикал Ко., Лтд. |
Пирроло[2,3-d]пиримидиновое соединение или его соль
|
|
KR101771219B1
(ko)
*
|
2015-08-21 |
2017-09-05 |
양지화학 주식회사 |
야누스 키나제 1 선택적 억제제 및 그 의약 용도
|
|
WO2017046675A1
(en)
|
2015-09-14 |
2017-03-23 |
Pfizer Inc. |
Novel imidazo [4,5-c] quinoline and imidazo [4,5-c][1,5] naphthyridine derivatives as lrrk2 inhibitors
|
|
US10045981B2
(en)
|
2015-11-24 |
2018-08-14 |
Jakpharm, Llc |
Selective kinase inhibitors
|
|
CN107098908B
(zh)
*
|
2016-02-23 |
2021-01-08 |
欣凯医药科技(上海)有限公司 |
一种吡咯并嘧啶类化合物的制备方法和应用
|
|
KR102419524B1
(ko)
|
2016-03-16 |
2022-07-08 |
쿠라 온콜로지, 인크. |
메닌-mll의 가교된 이환식 억제제 및 사용 방법
|
|
MD3429591T2
(ro)
|
2016-03-16 |
2023-08-31 |
Kura Oncology Inc |
Derivați de tieno[2,3-d]pirimidină substituiți în calitate de inhibitori ai menin-MLL și procedee de utilizare
|
|
CN107513067A
(zh)
|
2016-06-16 |
2017-12-26 |
北京赛林泰医药技术有限公司 |
含有取代环戊基的吡咯并嘧啶化合物
|
|
CN107513069A
(zh)
*
|
2016-06-16 |
2017-12-26 |
正大天晴药业集团股份有限公司 |
手性吡咯并嘧啶化合物的制备方法
|
|
AU2017298035B2
(en)
|
2016-07-21 |
2021-10-28 |
Biogen Ma Inc. |
Succinate forms and compositions of Bruton's tyrosine kinase inhibitors
|
|
US10316038B2
(en)
|
2017-01-25 |
2019-06-11 |
Aclaris Therapeutics, Inc. |
Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
|
|
WO2018141842A1
(en)
*
|
2017-02-03 |
2018-08-09 |
Leo Pharma A/S |
5-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NOVEL JAK KINASE INHIBITORS
|
|
US11944627B2
(en)
|
2017-03-24 |
2024-04-02 |
Kura Oncology, Inc. |
Methods for treating hematological malignancies and Ewing's sarcoma
|
|
CN108794480A
(zh)
*
|
2017-04-28 |
2018-11-13 |
天津药物研究院有限公司 |
吡咯并嘧啶类化合物、其制备方法和用途
|
|
WO2018226976A1
(en)
|
2017-06-08 |
2018-12-13 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
|
WO2019060365A1
(en)
|
2017-09-20 |
2019-03-28 |
Kura Oncology, Inc. |
SUBSTITUTED MÉNINE-MLL INHIBITORS AND METHODS OF USE
|
|
AU2018360059B2
(en)
|
2017-11-03 |
2023-07-13 |
Aclaris Therapeutics, Inc. |
Substituted pyrrolopyrimidine JAK inhibitors and methods of making and using the same
|
|
WO2019090143A1
(en)
|
2017-11-03 |
2019-05-09 |
Aclaris Therapeutics, Inc. |
Pyrazolyl pyrrolo[2,3-b]pyrimidine-5-carboxylate analogs and methods of making the same
|
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
CN112105608B
(zh)
|
2018-01-30 |
2023-07-14 |
因赛特公司 |
制备(1-(3-氟-2-(三氟甲基)异烟碱基)哌啶-4-酮)的方法
|
|
MX2020010322A
(es)
|
2018-03-30 |
2022-11-30 |
Incyte Corp |
Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de actividad de la cinasa janus (jak).
|
|
CA3109192A1
(en)
|
2018-08-10 |
2020-02-13 |
Aclaris Therapeutics, Inc. |
Pyrrolopyrimidine itk inhibitors
|
|
GB201818750D0
(en)
*
|
2018-11-16 |
2019-01-02 |
Institute Of Cancer Res Royal Cancer Hospital |
Lox inhibitors
|
|
CN109394768B
(zh)
*
|
2018-12-10 |
2019-08-23 |
牡丹江医学院 |
一种治疗湿疹的药物及其制备方法
|
|
CN113993585A
(zh)
*
|
2019-03-27 |
2022-01-28 |
英矽智能科技知识产权有限公司 |
双环jak抑制剂及其用途
|
|
SG11202108927UA
(en)
|
2019-05-02 |
2021-09-29 |
Aclaris Therapeutics Inc |
Substituted pyrrolopyridines as jak inhibitors
|
|
JOP20210298A1
(ar)
|
2019-05-14 |
2023-01-30 |
Provention Bio Inc |
طرق وتركيبات للوقاية من مرض السكري من النوع الأول
|
|
EP4061367A1
(en)
|
2019-11-22 |
2022-09-28 |
Incyte Corporation |
Combination therapy comprising an alk2 inhibitor and a jak2 inhibitor
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
KR20230092863A
(ko)
|
2020-06-11 |
2023-06-26 |
프로벤션 바이오, 인코포레이티드 |
제1형 당뇨병을 예방하기 위한 방법 및 조성물
|
|
WO2023055731A1
(en)
*
|
2021-09-28 |
2023-04-06 |
Sanford Burnham Prebys Medical Discovery Institute |
Inhibitors of serine/threonine protein kinase stk3 or stk4 and uses thereof
|